Premium Tapinarof API in Pakistan: Reliable Raw Material Supply for Pharmaceutical Formulators

Product Name: Tapinarof (Active Pharmaceutical Ingredient)

Supplier / Distributor: Morgan

Therapeutic Category: Aryl Hydrocarbon Receptor (AhR) Agonist

Indications: Plaque Psoriasis, Atopic Dermatitis

Compliance Notice: This technical data page is strictly for B2B pharmaceutical manufacturers, contract manufacturing organizations (CMOs), and analytical laboratories. The Tapinarof distributed by Morgan is a highly purified Active Pharmaceutical Ingredient (API) intended exclusively for commercial formulation and laboratory R&D. It is not a finished drug product.

About Morgan: Morgan Chemicals (Pvt.) Ltd. is a pharmaceutical raw material trading and distribution company. We source APIs from DRAP-registered and internationally certified manufacturers and supply exclusively to licensed pharmaceutical companies, CMOs, and research facilities. We do not manufacture APIs or sell finished medicines.

Product Overview and Mechanism of Action

Tapinarof is a first-in-class, non-steroidal small-molecule Active Pharmaceutical Ingredient (API). In dermatological pharmacology, it is classified as a therapeutic aryl hydrocarbon receptor (AhR) modulating agent. For pharmaceutical manufacturers focused on expanding their topical dermatology portfolios, this API represents a significant advancement in the localized management of chronic inflammatory skin conditions.

The pharmacological profile of Tapinarof diverges entirely from traditional topical corticosteroids, calcineurin inhibitors, or vitamin D analogues. At the cellular level, the API functions as a direct agonist of the aryl hydrocarbon receptor (AhR), a ligand-dependent transcription factor widely expressed in skin cells, including keratinocytes and immune cells.

Upon binding, the Tapinarof-AhR complex translocates to the nucleus, modulating the expression of specific target genes. This mechanism yields a trifecta of therapeutic effects in psoriatic and eczematous skin:

• Immunomodulation: It directly downregulates the production of pro-inflammatory cytokines, specifically T-helper 17 (Th17) cytokines such as IL-17A and IL-17F.
• Skin Barrier Restoration: It upregulates the transcription of critical epidermal barrier proteins, including filaggrin and loricrin, normalizing keratinocyte differentiation.
• Oxidative Stress Reduction: It activates the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway, inducing the expression of antioxidant enzymes that scavenge reactive oxygen species (ROS).

For pharmaceutical formulation scientists, integrating this API enables the development of highly effective, steroid-free topical therapeutics. In commercial manufacturing, this active ingredient is standardly formulated into a 1% topical cream.

Sourcing Tapinarof in Pakistan: Morgan’s Supply Network

Developing and commercializing advanced dermatological formulations requires a highly resilient and traceable raw material pipeline. Procuring specialty non-steroidal APIs for local commercial manufacturing frequently involves navigating extended lead times, stringent customs bottlenecks, and highly complex regulatory compliance. Sourcing Tapinarof Pakistan through Morgan’s localized distribution network mitigates these complex supply chain risks.

Morgan sources commercial-scale and pilot-scale quantities from global manufacturing partners operating in strict adherence to ICH Q7 Good Manufacturing Practice (GMP) guidelines. Partnering with Morgan as your primary supply vendor secures several operational provisions for your manufacturing facility:

• DRAP Submission Assistance: Morgan coordinates with DRAP-registered API manufacturers to obtain and forward the necessary compliance documentation on your behalf. This includes the open part of the Drug Master File (DMF), comprehensive impurity profiles, and accelerated stability data to strictly support your Drug Regulatory Authority of Pakistan (DRAP) dossier submissions.
• Supply Chain Stability: Our localized API inventory management eliminates international transit variables. Whether you require a standard pilot batch or are scaling up a high-volume Tapinarof api Pakistan procurement order, we help ensure that your commercial batch schedules and production timelines are met without costly line stoppages or raw material shortages.
• Batch-to-Batch Uniformity: Every shipment coordinated by Morgan includes a detailed Certificate of Analysis (CoA) issued by the original manufacturer. We ensure our supplied batches maintain consistent chemical purity, controlled moisture limits, and a precise particle size distribution (PSD) for predictable behavior during compounding and emulsification processes.

Technical Specifications for QA & R&D

The Tapinarof API supplied by Morgan undergoes exacting analytical testing at the source to meet current international pharmacopeial standards.

• Chemical Name: 3,5-Dihydroxy-4-isopropylstilbene (or 5-[(E)-2-phenylethenyl]-2-propan-2-ylbenzene-1,3-diol)
• CAS Number: 79338-84-4
• Appearance: Pale brown to light brown crystalline solid powder
• Molecular Formula: C17H18O2
• Molecular Weight: 254.33 g/mol
• Assay / Purity (HPLC): ≥ 99.0%
• Solubility Profile: Insoluble in water; soluble in specific organic solvents (such as DMSO and ethanol). Detailed solubility parameters are documented in the technical data sheet to assist your analytical R&D teams with vehicle selection and pre-formulation stability studies.

Manufacturing and Handling Guidelines for Formulators

While Tapinarof is utilized as a topical agent with minimal systemic absorption in its finished form, the pure unformulated API is a highly concentrated pharmacologically active compound. Facilities processing this API must enforce strict occupational exposure limits (OEL) to protect personnel on the manufacturing floor.

• Storage Conditions: Store the raw API powder in securely closed, light-resistant containers. Maintain climate-controlled conditions as specified by the batch protocol (typically refrigerated at 2-8°C or controlled room temperature, strictly protected from excessive heat and ambient humidity) to prevent degradation and maintain structural integrity.
• Occupational Safety: Personnel handling the pure API powder must follow advanced industrial containment protocols. Processing requires appropriate Personal Protective Equipment (PPE), including P3/N95 industrial dust masks or respirators, chemical-resistant nitrile gloves, and full protective facility garments. Dispensing, milling, and compounding stages must be executed within localized exhaust ventilation systems or dedicated negative-pressure weighing booths to prevent the inhalation of airborne particulates and facility cross-contamination.

Distributor Disclaimer: Morgan Chemicals is a pharmaceutical raw material trading and distribution company. This API is sourced from DRAP-registered, GMP-certified manufacturing partners. Morgan Chemicals does not manufacture APIs, does not hold DRAP manufacturing registration, and does not sell finished medicines. This product is supplied exclusively to licensed pharmaceutical companies, CMOs, and research facilities in Pakistan — not for individual or consumer sale.